IP Library Granted Patent US 7,919,303
Granted Patent B2
US 7,919,303 · App. 12/879,862 · Granted Apr 5, 2011

Methods and compositions for the recombinant biosynthesis of

Assignee: Joule Unlimited, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,919,303
App. No.
12/879,862
Granted
Apr 5, 2011
Kind
B2
Abstract

The present disclosure identifies methods and compositions for modifying photoautotrophic organisms as hosts, such that the organisms efficiently convert carbon dioxide and light into n-alkanes, and in particular the use of such organisms for the commercial production of n-alkanes and related molecules.

Claims (8)

1. An engineered cyanobacterium, wherein said engineered cyanobacterium comprises a recombinant acyl-ACP reductase enzyme and a recombinant alkanal decarboxylative monooxygenase enzyme; and wherein said cyanobacterium, when cultured in the presence of light and carbon dioxide, produces n-alkanes, wherein at least one of said n-alkanes is selected from the group consisting of n-tridecane, n-tetradecane, n-pentadecane, n-hexadecane, and n-heptadecane, and wherein the amount of said n-alkanes produced is between 0.1% and 5% dry cell weight and at least two times the amount produced by an otherwise identical cyanobacterium, cultured under identical conditions, but lacking said recombinant acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes.

2. The engineered cyanobacterium of claim 1 , wherein said enzymes are encoded by genes which are present in multiple copies in said engineered cyanobacterium.

3. The engineered cyanobacterium of claim 2 , wherein said enzymes are encoded by a plasmid.

4. The engineered cyanobacterium of claim 1 , wherein said enzymes are encoded by genes which are part of an operon, and wherein the expression of said genes is controlled by a single promoter.

5. The engineered cyanobacterium of claim 3 , wherein said enzymes are encoded by genes which are part of an operon, and wherein the expression of said genes is controlled by a single promoter.

6. The engineered cyanobacterium of claim 1 , wherein expression of the recombinant acyl-ACP reductase or alkanal decarboxylative monooxygenase enzymes in said engineered cyanobacterium is controlled by a promoter selected from the group consisting of a cI promoter, a cpcB promoter, a lacI-trc promoter, an EM7 promoter, and an aphII promoter.

7. The engineered cyanobacterium of claim 3 , wherein expression of the recombinant acyl-ACP reductase or alkanal decarboxylative monooxygenase enzymes in said engineered cyanobacterium is controlled by a promoter selected from the group consisting of a cI promoter, a cpcB promoter, a lacI-trc promoter, an EM7 promoter, and a aphII promoter.

8. The engineered cyanobacterium of claim 1 , wherein said engineered cyanobacterium is a thermophile.

Assignments (3)
SECURITY INTEREST Recorded Jun 23, 2016
From: JOULE UNLIMITED TECHNOLOGIES, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 039140/0200 →
CHANGE OF NAME Recorded Sep 20, 2011
From: JOULE UNLIMITED, INC.
To: JOULE UNLIMITED TECHNOLOGIES, INC.
Reel/Frame 026938/0365 →
CHANGE OF NAME Recorded Mar 9, 2011
From: JOULE BIOTECHNOLOGIES, INC.
To: JOULE UNLIMITED, INC.
Reel/Frame 025930/0013 →
Continuity (4)
Continuation 12759657 · Apr 13, 2010
Provisional Application 61224463 · Jul 9, 2009
Provisional Application 61228937 · Jul 27, 2009
Related Publication 20110009674A1 · Jan 13, 2011